UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer

Annals of oncology, 2018-02, Vol.29 (2), p.517-518

2018

Link zum Volltext

Verfügbarkeit prüfen

Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients

Annals of oncology, 2021-08, Vol.32 (8), p.1051-1053

2021

Link zum Volltext

Verfügbarkeit prüfen

PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

Annals of oncology, 2018-04, Vol.29 (4), p.1065-1066

2018

Link zum Volltext

Verfügbarkeit prüfen

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers

Annals of oncology, 2021-10, Vol.32 (10), p.1294-1295

2021

Link zum Volltext

Verfügbarkeit prüfen

Genetic landscape of indolent and aggressive Kaposi sarcomas

Journal of the European Academy of Dermatology and Venereology, 2022-12, Vol.36 (12), p.2343-2351

2022

Link zum Volltext

Verfügbarkeit prüfen

Management of hypertension in angiogenesis inhibitor-treated patients

Annals of oncology, 2009-05, Vol.20 (5), p.807-815

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of EGFR expression on colorectal cancer patient prognosis and survival

Annals of oncology, 2005-01, Vol.16 (1), p.102-108

2005

Link zum Volltext

Verfügbarkeit prüfen

Nasopharyngeal carcinomas: an update

European Journal of Cancer, 2003-10, Vol.39 (15), p.2121-2135

2003

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives

Annals of oncology, 2005-02, Vol.16 (2), p.189-194

2005

Link zum Volltext

Verfügbarkeit prüfen

Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome

Annals of oncology, 2004-04, Vol.15 (4), p.613-617

2004

Link zum Volltext

Verfügbarkeit prüfen

Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study

European journal of cancer (1990), 2017-09, Vol.82, p.230-236

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

ESMO open, 2022-08, Vol.7 (4), p.100529-100529, Article 100529

2022

Link zum Volltext

Verfügbarkeit prüfen

Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group

Annals of oncology, 2016-03, Vol.27 (3), p.397-408

2016

Link zum Volltext

Verfügbarkeit prüfen

Invasive cervical cancer in HIV‐infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)–Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study

HIV medicine, 2019-03, Vol.20 (3), p.222-229

2019

Link zum Volltext

Verfügbarkeit prüfen

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer

Annals of oncology, 2006-06, Vol.17 (6), p.945-951

2006

Link zum Volltext

Verfügbarkeit prüfen

Added value of molecular targeted agents in oncology

Annals of oncology, 2011-08, Vol.22 (8), p.1703-1716

2011

Link zum Volltext

Verfügbarkeit prüfen

Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?

Annals of oncology, 2009-03, Vol.20 (3), p.600-601

2009

Link zum Volltext

Verfügbarkeit prüfen

Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review

Annals of oncology, 2022-02, Vol.33 (2), p.158-168

2022

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy for HIV-infected patients

Cancer radiothérapie, 2018-10, Vol.22 (6-7), p.496-501

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours

European journal of cancer (1990), 2017-08, Vol.81, p.81-89

2017

Link zum Volltext

Verfügbarkeit prüfen

Tolerance and efficacy of immune-checkpoint inhibitors for cancer in people living with HIV (PWHIV)

Annals of oncology, 2018-10, Vol.29, p.viii733-viii733

2018

Link zum Volltext

Verfügbarkeit prüfen

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA

Breast (Edinburgh), 2015-08, Vol.24 (4), p.376-383

2015

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer

Annals of oncology, 2008-12, Vol.19 (12), p.2033-2038

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic (PD) changes in tumors and peripheral blood T cell receptor (TCR) repertoire in a phase I study combining OX40 (PF-04518600) and 4-1BB (utomilumab) agonistic monoclonal antibodies (mAbs)

Annals of oncology, 2018-10, Vol.29, p.viii422-viii422

2018

Link zum Volltext

Verfügbarkeit prüfen

Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study

ESMO open, 2022-12, Vol.7 (6), p.100650, Article 100650

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(136)
Life Sciences & Biomedicine
(123)
Humans
(119)
Oncology
(80)
Male
(63)
Female
(60)
Biological And Medical Sciences
(51)
Adult
(44)
Medical Sciences
(44)
Middle Aged
(40)
Aged
(27)
Prognosis
(23)
Cancer
(22)
Tumors
(21)
Life Sciences
(19)
Pharmacology. Drug Treatments
(16)
Aged, 80 And Over
(15)
Antineoplastic Agents - Therapeutic Use
(15)
Medicin Och Hälsovetenskap
(15)
Sciences Biologiques Et Medicales
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer

Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients

PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers

Genetic landscape of indolent and aggressive Kaposi sarcomas

Management of hypertension in angiogenesis inhibitor-treated patients

Impact of EGFR expression on colorectal cancer patient prognosis and survival

Nasopharyngeal carcinomas: an update

Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives

Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome

Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group

Invasive cervical cancer in HIV‐infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)–Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer

Added value of molecular targeted agents in oncology

Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?

Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review

Radiotherapy for HIV-infected patients

Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours

Tolerance and efficacy of immune-checkpoint inhibitors for cancer in people living with HIV (PWHIV)

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA

Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer

Pharmacodynamic (PD) changes in tumors and peripheral blood T cell receptor (TCR) repertoire in a phase I study combining OX40 (PF-04518600) and 4-1BB (utomilumab) agonistic monoclonal antibodies (mAbs)

Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study

Suchergebnisse filtern